Overall, these data identify CTBP1/2 as new ZBTB18 interactors in GBM cells and suggest that ZBTB18 might employ both a CTBP-dependent and a CTBP-independent mechanism to repress target genes and mediate its tumor suppressor functions. This evidence concerns the gene CTBP1 and glioblastoma.